skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 458  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: language: Norwegian remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Outcome measures in coeliac disease trials: the Tampere recommendations
Material Type:
Article
Add to My Research

Outcome measures in coeliac disease trials: the Tampere recommendations

Gut, 2018-08, Vol.67 (8), p.1410-1424 [Peer Reviewed Journal]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;Copyright: 2018 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;info:eu-repo/semantics/openAccess ;Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2018 ;ISSN: 0017-5749 ;ISSN: 1468-3288 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2017-314853 ;PMID: 29440464

Full text available

2
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
Material Type:
Article
Add to My Research

International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

The lancet oncology, 2019-06, Vol.20 (6), p.e302-e312 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;info:eu-repo/semantics/openAccess ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30309-2 ;PMID: 31162104

Full text available

3
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Material Type:
Article
Add to My Research

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Annals of oncology, 2019-05, Vol.30 (5), p.672-705 [Peer Reviewed Journal]

The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;info:eu-repo/semantics/openAccess ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz062 ;PMID: 31046081

Full text available

4
Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes
Material Type:
Article
Add to My Research

Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes

Annals of hematology, 2022-10, Vol.101 (10), p.2123-2137 [Peer Reviewed Journal]

The Author(s) 2022 ;2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;ISSN: 0939-5555 ;EISSN: 1432-0584 ;DOI: 10.1007/s00277-022-04917-5 ;PMID: 35943588

Full text available

5
Mushroom extracts and compounds with suppressive action on breast cancer: evidence from studies using cultured cancer cells, tumor-bearing animals, and clinical trials
Material Type:
Article
Add to My Research

Mushroom extracts and compounds with suppressive action on breast cancer: evidence from studies using cultured cancer cells, tumor-bearing animals, and clinical trials

Applied microbiology and biotechnology, 2020-06, Vol.104 (11), p.4675-4703 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2020 ;COPYRIGHT 2020 Springer ;Springer-Verlag GmbH Germany, part of Springer Nature 2020. ;info:eu-repo/semantics/openAccess ;ISSN: 0175-7598 ;EISSN: 1432-0614 ;DOI: 10.1007/s00253-020-10476-4 ;PMID: 32274562

Full text available

6
How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study
Material Type:
Article
Add to My Research

How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study

Diabetes, obesity & metabolism, 2019-04, Vol.21 (4), p.968

info:eu-repo/semantics/openAccess ;ISSN: 1462-8902 ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.13612

Digital Resources/Online E-Resources

7
Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial
Material Type:
Article
Add to My Research

Cancer cachexia: rationale for the MENAC (Multimodal—Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial

BMJ supportive & palliative care, 2018-09, Vol.8 (3), p.258-265 [Peer Reviewed Journal]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;info:eu-repo/semantics/openAccess ;ISSN: 2045-435X ;EISSN: 2045-4368 ;DOI: 10.1136/bmjspcare-2017-001440 ;PMID: 29440149

Full text available

8
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
Material Type:
Article
Add to My Research

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

The Lancet (British edition), 2019-01, Vol.393 (10168), p.253-264 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 19, 2019 ;info:eu-repo/semantics/openAccess ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)33003-4 ;PMID: 30545780

Full text available

9
Integration of oncology and palliative care: a Lancet Oncology Commission
Material Type:
Article
Add to My Research

Integration of oncology and palliative care: a Lancet Oncology Commission

The lancet oncology, 2018-11, Vol.19 (11), p.e588-e653 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Nov 2018 ;info:eu-repo/semantics/openAccess ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(18)30415-7 ;PMID: 30344075

Full text available

10
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
Material Type:
Article
Add to My Research

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

The Lancet (British edition), 2017-02, Vol.389 (10068), p.505-518 [Peer Reviewed Journal]

World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. ;2017 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. ;Copyright © 2017 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Feb 4, 2017 ;2017. World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. ;info:eu-repo/semantics/openAccess ;2017 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)32621-6 ;PMID: 28017403 ;CODEN: LANCAO

Full text available

11
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Material Type:
Article
Add to My Research

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Nature communications, 2021-04, Vol.12 (1), p.2349-13, Article 2349 [Peer Reviewed Journal]

The Author(s) 2021. corrected publication 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;The Author(s) 2021, corrected publication 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-22446-z ;PMID: 33859192

Full text available

12
Immune Thrombocytopenia
Material Type:
Article
Add to My Research

Immune Thrombocytopenia

The New England journal of medicine, 2019-09, Vol.381 (10), p.945-955 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;info:eu-repo/semantics/openAccess ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMcp1810479 ;PMID: 31483965

Full text available

13
Drug treatments for covid-19: living systematic review and network meta-analysis
Material Type:
Article
Add to My Research

Drug treatments for covid-19: living systematic review and network meta-analysis

BMJ, 2020-07, Vol.370, p.m2980 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m2980 ;PMID: 32732190

Digital Resources/Online E-Resources

14
Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial
Material Type:
Article
Add to My Research

Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial

Clinical cancer research, 2023-08, Vol.29 (16), p.3026-3036 [Peer Reviewed Journal]

2023 The Authors; Published by the American Association for Cancer Research. ;info:eu-repo/semantics/openAccess ;2023 The Authors; Published by the American Association for Cancer Research 2023 American Association for Cancer Research ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-23-0416 ;PMID: 37378632

Full text available

15
Correlation between MRI morphological response patterns and histopathological tumor regression after neoadjuvant endocrine therapy in locally advanced breast cancer: a randomized phase II trial
Material Type:
Article
Add to My Research

Correlation between MRI morphological response patterns and histopathological tumor regression after neoadjuvant endocrine therapy in locally advanced breast cancer: a randomized phase II trial

Breast cancer research and treatment, 2021-10, Vol.189 (3), p.711-723 [Peer Reviewed Journal]

The Author(s) 2021 ;2021. The Author(s). ;COPYRIGHT 2021 Springer ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-021-06343-z ;PMID: 34357493

Full text available

16
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials
Material Type:
Article
Add to My Research

Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials

Breast cancer research and treatment, 2024-04, Vol.204 (2), p.249-259 [Peer Reviewed Journal]

The Author(s) 2023 ;info:eu-repo/semantics/openAccess ;ISSN: 0167-6806 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-023-07147-z

Digital Resources/Online E-Resources

17
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Material Type:
Article
Add to My Research

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2

Nature (London), 2023-03, Vol.615 (7950), p.134-142 [Peer Reviewed Journal]

2022. The Author(s). ;Copyright Nature Publishing Group Mar 2, 2023 ;info:eu-repo/semantics/openAccess ;The Author(s) 2022 ;ISSN: 0028-0836 ;ISSN: 1476-4687 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-05594-0 ;PMID: 36470304

Full text available

18
An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination
Material Type:
Article
Add to My Research

An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination

Journal of Thrombosis and Haemostasis, 2021-07 [Peer Reviewed Journal]

2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;info:eu-repo/semantics/openAccess ;ISSN: 1538-7933 ;EISSN: 1538-7836 ;DOI: 10.1111/jth.15352

Digital Resources/Online E-Resources

19
Essential Fatty Acid Supplementation and Early Inflammation in Preterm Infants: Secondary Analysis of a Randomized Clinical Trial
Material Type:
Article
Add to My Research

Essential Fatty Acid Supplementation and Early Inflammation in Preterm Infants: Secondary Analysis of a Randomized Clinical Trial

Neonatology (Basel, Switzerland), 2023-08, Vol.120 (4), p.465-472 [Peer Reviewed Journal]

2023 The Author(s). Published by S. Karger AG, Basel ;info:eu-repo/semantics/openAccess ;ISSN: 1661-7800 ;EISSN: 1661-7819 ;DOI: 10.1159/000530129 ;PMID: 37121228

Digital Resources/Online E-Resources

20
Homocysteine and Dementia: An International Consensus Statement
Material Type:
Article
Add to My Research

Homocysteine and Dementia: An International Consensus Statement

Journal of Alzheimer's disease, 2018-01, Vol.62 (2), p.561 [Peer Reviewed Journal]

info:eu-repo/semantics/openAccess ;ISSN: 1387-2877 ;ISSN: 1875-8908 ;EISSN: 1875-8908 ;DOI: 10.3233/JAD-171042

Digital Resources/Online E-Resources

Results 1 - 20 of 458  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (446)

Refine My Results

Creation Date 

From To
  1. Before 2004  (63)
  2. 2004 To 2008  (20)
  3. 2009 To 2013  (23)
  4. 2014 To 2019  (107)
  5. After 2019  (246)
  6. More options open sub menu

Searching Remote Databases, Please Wait